Archives

by in
Entry Author Date Location
XBiotech Takes Aim at Inflammation That Weakens Cancer Patients 05/17/13 Texas
Radius Health CEO: Skin Patch Data is the Value Driver 05/13/13 Boston
Biotech Execs Aren’t Ready to Prove Drugs Have Value, E&Y Says 04/23/13 National
Michigan Life Sciences Roundup: Swift Biosciences, Aastrom 03/11/13 Detroit
UW Spinoff Resolve Therapeutics Lures In Takeda, Lines Up Return 02/27/13 Seattle
Third Rock’s Bet on Lotus Tissue Repair Generates Big Return 02/27/13 Boston
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
East Coast Life Sciences Roundup: Pfizer, J&J, Alkermes, More 01/04/13 Boston
Alkermes Aims for Psychiatric Drug That Won’t Pack on the Pounds 01/03/13 Boston
East Coast Life Sciences Roundup: Zafgen, Moderna, Merck, More 12/07/12 Boston
Moderna, $40M in Tow, Hopes to Reinvent Biotech with “Make Your Own Drug” 12/06/12 Boston
Where’s the Can-Do Spirit in Biotech? It’s Alive, Deep Down 12/03/12 National
Janssen Forms “Investigator Databank” to Help Streamline Drug Trials 11/15/12 San Diego
UW Spinoff Resolve Therapeutics Snags $5.8M for Lupus Drug 11/01/12 Seattle
Calling All Seattle Biotechies: The Icos Impact Is Coming Up Nov. 27 10/18/12 Seattle
Celgene Puts $35M into VentiRx, Gets Option to Buy Cancer Drugmaker 10/03/12 Seattle
Roche Picks New Big Apple Tower as Home for Research Center 09/21/12 New York
Join Cliff Stocks, Pat Gray, Mike Gallatin & More Nov. 27 for ‘The Icos Impact’ 09/20/12 Seattle
Alzheimer’s R&D Isn’t Doomed, it’s Learning From Failure 08/20/12 National
Juliet Marine’s “Ghost” Ship Emerges from Stealth Startup, Gears Up for War 06/21/12 Boston
Flexion Overhaul Bears Fruit With Upbeat Data From Arthritis Trial 05/30/12 Boston
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
NIH’s Collins Lauds “Unprecedented” Partnership at NY Bio Confab 05/04/12 New York
Amylin Booms on Report it Rejected Bristol’s $3.5B Takeover Bid 03/28/12 San Diego
CytomX Therapeutics Seeks to One-Up Lilly, Amgen Cancer Drugs 03/02/12 San Francisco
Dendreon Adds ImClone Vets to New Management Team 02/28/12 Seattle
Satori Cultivates Prolific Herb for Promising Alzheimer’s Weapon 02/28/12 Boston
Satori Snaps Up $15M for Alzheimer’s Drugs 02/23/12 Boston
FDA vs. Drug Ads: Cut the Kids and Dogs, Spell Out Side Effects 02/06/12 National
Clarus Ventures Adjusts to Unpredictable Biotech World 01/20/12 Boston
Page 1 of 9 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  2. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.